{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:48:10Z","timestamp":1789152490881,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Open Cooperation Program of Beijing Brain Science and Brain-like Research Center Scientific Research","award":["2020-NKX-XM-02"],"award-info":[{"award-number":["2020-NKX-XM-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89426-x","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:27:05Z","timestamp":1740137225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Aberrant activation of the mTOR signaling pathway in Rasmussen encephalitis"],"prefix":"10.1038","volume":"15","author":[{"given":"Jiao","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingguo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingkun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoxue","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoyun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoming","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"issue":"2","key":"89426_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1474-4422(13)70260-6","volume":"13","author":"S Varadkar","year":"2014","unstructured":"Varadkar, S. et al. Rasmussen\u2019s encephalitis: clinical features, pathobiology, and treatment advances[J]. Lancet Neurol. 13 (2), 195\u2013205 (2014).","journal-title":"Lancet Neurol."},{"issue":"1","key":"89426_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/epi.17131","volume":"63","author":"S Fauser","year":"2022","unstructured":"Fauser, S. et al. Rasmussen encephalitis: predisposing factors and their potential role in unilaterality[J]. Epilepsia 63 (1), 108\u2013119 (2022).","journal-title":"Epilepsia"},{"issue":"3","key":"89426_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/epi.12042","volume":"54","author":"CG Bien","year":"2013","unstructured":"Bien, C. G. et al. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins[J]. Epilepsia 54 (3), 543\u2013550 (2013).","journal-title":"Epilepsia"},{"issue":"5","key":"89426_CR4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.0013-9580.2004.33103.x","volume":"45","author":"CA Pardo","year":"2004","unstructured":"Pardo, C. A. et al. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies[J]. Epilepsia 45 (5), 516\u2013526 (2004).","journal-title":"Epilepsia"},{"issue":"1","key":"89426_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1227\/neu.0000000000001958","volume":"91","author":"SJ Sundar","year":"2022","unstructured":"Sundar, S. J. et al. Seizure outcomes and reoperation in Surgical Rasmussen Encephalitis Patients[J]. Neurosurgery 91 (1), 93\u2013102 (2022).","journal-title":"Neurosurgery"},{"key":"89426_CR6","doi-asserted-by":"publisher","first-page":"106144","DOI":"10.1016\/j.nbd.2023.106144","volume":"182","author":"A Gerasimenko","year":"2023","unstructured":"Gerasimenko, A., Baldassari, S. & Baulac, S. mTOR pathway: insights into an established pathway for brain mosaicism in epilepsy[J]. Neurobiol. Dis. 182, 106144 (2023).","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"89426_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar, V. et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease[J]. Signal. Transduct. Target. Ther. 8 (1), 375 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"3","key":"89426_CR8","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","volume":"101","author":"A Szwed","year":"2021","unstructured":"Szwed, A., Kim, E. & Jacinto, E. Regulation and metabolic functions of mTORC1 and mTORC2[J]. Physiol. Rev. 101 (3), 1371\u20131426 (2021).","journal-title":"Physiol. Rev."},{"key":"89426_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcdb.2014.09.011","volume":"36","author":"K Huang","year":"2014","unstructured":"Huang, K. & Fingar, D. C. Growing knowledge of the mTOR signaling network[J]. Semin Cell. Dev. Biol. 36, 79\u201390 (2014).","journal-title":"Semin Cell. Dev. Biol."},{"issue":"17","key":"89426_CR10","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/onc.2014.164","volume":"34","author":"KM Dodd","year":"2015","unstructured":"Dodd, K. M. et al. mTORC1 drives HIF-1\u03b1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3[J]. Oncogene 34 (17), 2239\u20132250 (2015).","journal-title":"Oncogene"},{"issue":"2","key":"89426_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.molcel.2015.05.030","volume":"59","author":"E Arias","year":"2015","unstructured":"Arias, E. et al. Lysosomal mTORC2\/PHLPP1\/Akt regulate chaperone-mediated Autophagy[J]. Mol. Cell. 59 (2), 270\u2013284 (2015).","journal-title":"Mol. Cell"},{"key":"89426_CR12","doi-asserted-by":"crossref","unstructured":"Lee, W. S. et al. Cortical dysplasia and the mTOR pathway: how the study of human brain tissue has led to insights into Epileptogenesis[J]. Int. J. Mol. Sci. 23(3), 1344 (2022).","DOI":"10.3390\/ijms23031344"},{"issue":"1","key":"89426_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/2051-5960-2-71","volume":"2","author":"J Liu","year":"2014","unstructured":"Liu, J. et al. Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies[J]. Acta Neuropathol. Commun. 2 (1), 71 (2014).","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"89426_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/epi.17457","volume":"64","author":"DF Leitner","year":"2023","unstructured":"Leitner, D. F. et al. Brain molecular mechanisms in Rasmussen encephalitis[J]. Epilepsia 64 (1), 218\u2013230 (2023).","journal-title":"Epilepsia"},{"issue":"Pt 3","key":"89426_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/brain\/awh415","volume":"128","author":"CG Bien","year":"2005","unstructured":"Bien, C. G. et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement[J]. Brain 128 (Pt 3), 454\u2013471 (2005).","journal-title":"Brain"},{"issue":"2","key":"89426_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/bpa.12770","volume":"30","author":"X He","year":"2020","unstructured":"He, X. et al. Upregulation of adenosine A2A receptor and downregulation of GLT1 is associated with neuronal cell death in Rasmussen\u2019s encephalitis[J]. Brain Pathol. 30 (2), 246\u2013260 (2020).","journal-title":"Brain Pathol."},{"key":"89426_CR17","doi-asserted-by":"crossref","unstructured":"Reichenbach, N. et al. Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer\u2019s disease model[J]. EMBO Mol. Med. 11(2), e9665 (2019).","DOI":"10.15252\/emmm.201809665"},{"issue":"4","key":"89426_CR18","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ana.20211","volume":"56","author":"M Baybis","year":"2004","unstructured":"Baybis, M. et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia[J]. Ann. Neurol. 56 (4), 478\u2013487 (2004).","journal-title":"Ann. Neurol."},{"issue":"4","key":"89426_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/ana.20234","volume":"56","author":"H Miyata","year":"2004","unstructured":"Miyata, H., Chiang, A. C. Y. & Vinters, H. V. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis[J]. Ann. Neurol. 56 (4), 510\u2013519 (2004).","journal-title":"Ann. Neurol."},{"issue":"3","key":"89426_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00401-007-0225-6","volume":"114","author":"E Aronica","year":"2007","unstructured":"Aronica, E. et al. Co-expression of cyclin D1 and phosphorylated ribosomal S6 proteins in hemimegalencephaly[J]. Acta Neuropathol. 114 (3), 287\u2013293 (2007).","journal-title":"Acta Neuropathol."},{"issue":"Suppl 1","key":"89426_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1528-1167.2012.03478.x","volume":"53","author":"AA Sosunov","year":"2012","unstructured":"Sosunov, A. A. et al. The mTOR pathway is activated in glial cells in mesial temporal sclerosis[J]. Epilepsia 53 (Suppl 1), 78\u201386 (2012).","journal-title":"Epilepsia"},{"issue":"Suppl 5","key":"89426_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1528-1167.2007.01291.x","volume":"48","author":"V Schick","year":"2007","unstructured":"Schick, V. et al. Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions[J]. Epilepsia 48 (Suppl 5), 65\u201373 (2007).","journal-title":"Epilepsia"},{"key":"89426_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.phrs.2016.03.039","volume":"107","author":"R Citraro","year":"2016","unstructured":"Citraro, R. et al. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis[J]. Pharmacol. Res. 107, 333\u2013343 (2016).","journal-title":"Pharmacol. Res."},{"key":"89426_CR24","doi-asserted-by":"crossref","unstructured":"Fudyma, I. A. & Wadhwani, N. R. Double pathology in Rasmussen Encephalitis[J]. Pediatr. Neurol. Briefs 34(0), 7 (2020).","DOI":"10.15844\/pedneurbriefs-34-7"},{"key":"89426_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/569170","volume":"2012","author":"RA Prayson","year":"2012","unstructured":"Prayson, R. A. Dual Pathology in Rasmussen\u2019s encephalitis: a report of Coexistent Focal Cortical Dysplasia and review of the Literature[J]. Case Rep. Pathol. 2012, 1\u20134 (2012).","journal-title":"Case Rep. Pathol."},{"issue":"5","key":"89426_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrm2672","volume":"10","author":"XM Ma","year":"2009","unstructured":"Ma, X. M. & Blenis, J. Molecular mechanisms of mTOR-mediated translational control[J]. Nat. Rev. Mol. Cell. Biol. 10 (5), 307\u2013318 (2009).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"11","key":"89426_CR27","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41591-019-0608-y","volume":"25","author":"CJ Chen","year":"2019","unstructured":"Chen, C. J. et al. Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency[J]. Nat. Med. 25 (11), 1684\u20131690 (2019).","journal-title":"Nat. Med."},{"issue":"2","key":"89426_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/glia.10151","volume":"40","author":"M Koistinaho","year":"2002","unstructured":"Koistinaho, M. & Koistinaho, J. Role of p38 and p44\/42 mitogen-activated protein kinases in microglia[J]. Glia 40 (2), 175\u2013183 (2002).","journal-title":"Glia"},{"issue":"2","key":"89426_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/neup.12242","volume":"36","author":"VV Patil","year":"2016","unstructured":"Patil, V. V. et al. Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia[J]. Neuropathology 36 (2), 146\u2013156 (2016).","journal-title":"Neuropathology"},{"issue":"41","key":"89426_CR30","doi-asserted-by":"publisher","first-page":"14389","DOI":"10.1523\/JNEUROSCI.3408-12.2012","volume":"32","author":"TL Beaumont","year":"2012","unstructured":"Beaumont, T. L. et al. Layer-specific CREB target gene induction in human neocortical epilepsy[J]. J. Neurosci. 32 (41), 14389\u201314401 (2012).","journal-title":"J. Neurosci."},{"issue":"Pt 2","key":"89426_CR31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/brain\/awu350","volume":"138","author":"F Dachet","year":"2015","unstructured":"Dachet, F. et al. Predicting novel histopathological microlesions in human epileptic brain through transcriptional clustering[J]. Brain 138 (Pt 2), 356\u2013370 (2015).","journal-title":"Brain"},{"issue":"8","key":"89426_CR32","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1468-1331.2007.01777.x","volume":"14","author":"ZQ Xi","year":"2007","unstructured":"Xi, Z. Q. et al. Extracellular signal-regulated protein kinase in human intractable epilepsy[J]. Eur. J. Neurol. 14 (8), 865\u2013872 (2007).","journal-title":"Eur. J. Neurol."},{"key":"89426_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.eplepsyres.2016.03.005","volume":"123","author":"G Luan","year":"2016","unstructured":"Luan, G. et al. Upregulation of HMGB1, toll-like receptor and RAGE in human Rasmussen\u2019s encephalitis[J]. Epilepsy Res. 123, 36\u201349 (2016).","journal-title":"Epilepsy Res."},{"issue":"2","key":"89426_CR34","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/glia.21094","volume":"59","author":"R Gorina","year":"2011","unstructured":"Gorina, R. et al. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NF\u03baB signaling, MAPK, and Jak1\/Stat1 pathways[J]. Glia 59 (2), 242\u2013255 (2011).","journal-title":"Glia"},{"key":"89426_CR35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbi.2019.04.010","volume":"80","author":"L Li","year":"2019","unstructured":"Li, L. et al. Toll-like receptor 9 antagonism modulates astrocyte function and preserves proximal axons following spinal cord injury[J]. Brain Behav. Immun. 80, 328\u2013343 (2019).","journal-title":"Brain Behav. Immun."},{"issue":"23","key":"89426_CR36","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1038\/sj.emboj.7601911","volume":"26","author":"AS Nateri","year":"2007","unstructured":"Nateri, A. S. et al. ERK activation causes epilepsy by stimulating NMDA receptor activity[J]. Embo j. 26 (23), 4891\u20134901 (2007).","journal-title":"Embo j."},{"key":"89426_CR37","doi-asserted-by":"publisher","first-page":"102100","DOI":"10.1016\/j.tice.2023.102100","volume":"82","author":"EG Lemus Silva","year":"2023","unstructured":"Lemus Silva, E. G. et al. Beclin 1 regulates astrocyte phagocytosis and phagosomal recruitment of retromer[J]. Tissue Cell. 82, 102100 (2023).","journal-title":"Tissue Cell."},{"issue":"7","key":"89426_CR38","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ncb2757","volume":"15","author":"RC Russell","year":"2013","unstructured":"Russell, R. C. et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase[J]. Nat. Cell. Biol. 15 (7), 741\u2013750 (2013).","journal-title":"Nat. Cell. Biol."},{"issue":"14","key":"89426_CR39","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1111\/jcmm.17421","volume":"26","author":"S Bhattacharya","year":"2022","unstructured":"Bhattacharya, S. et al. STAT3 suppresses the AMPK\u03b1\/ULK1-dependent induction of autophagy in glioblastoma cells[J]. J. Cell. Mol. Med. 26 (14), 3873\u20133890 (2022).","journal-title":"J. Cell. Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89426-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89426-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89426-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:27:14Z","timestamp":1740137234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89426-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89426"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89426-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"18 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethical Committee of Sanbo Brain Hospital, Capital Medical University approved the study under protocol SBNK-YJ-2020-015-01.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"6347"}}